| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |